125 related articles for article (PubMed ID: 29266259)
21. Revisiting OCT4 expression in peripheral blood mononuclear cells.
Kotoula V; Papamichos SI; Lambropoulos AF
Stem Cells; 2008 Jan; 26(1):290-1. PubMed ID: 17932416
[TBL] [Abstract][Full Text] [Related]
22. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
23. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
[TBL] [Abstract][Full Text] [Related]
25. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
26. OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6.
Chen Y; Wu Z; Zhu X; Zhang M; Zang X; Li X; Xu Y
Exp Neurol; 2019 Jun; 316():52-62. PubMed ID: 30981804
[TBL] [Abstract][Full Text] [Related]
27. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
Poursani EM; Mohammad Soltani B; Mowla SJ
Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
[TBL] [Abstract][Full Text] [Related]
28. The differential expression of OCT4 isoforms in cervical carcinoma.
Li SW; Wu XL; Dong CL; Xie XY; Wu JF; Zhang X
PLoS One; 2015; 10(3):e0118033. PubMed ID: 25816351
[TBL] [Abstract][Full Text] [Related]
29. Prognostication of OCT4 isoform expression in prostate cancer.
de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
[TBL] [Abstract][Full Text] [Related]
30. OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness.
Papamichos SI; Kotoula V; Tarlatzis BC; Agorastos T; Papazisis K; Lambropoulos AF
Mol Hum Reprod; 2009 May; 15(5):269-70. PubMed ID: 19258399
[TBL] [Abstract][Full Text] [Related]
31. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
32. Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency.
Choi HW; Joo JY; Hong YJ; Kim JS; Song H; Lee JW; Wu G; Schöler HR; Do JT
Stem Cell Reports; 2016 Nov; 7(5):911-926. PubMed ID: 28157483
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
34. Spatiotemporal dynamics of OCT4 protein localization during preimplantation development in mice.
Fukuda A; Mitani A; Miyashita T; Kobayashi H; Umezawa A; Akutsu H
Reproduction; 2016 Nov; 152(5):417-30. PubMed ID: 27495230
[TBL] [Abstract][Full Text] [Related]
35. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
37. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
38. OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.
Meng L; Hu H; Zhi H; Liu Y; Shi F; Zhang L; Zhou Y; Lin A
Oncol Lett; 2018 Jul; 16(1):522-528. PubMed ID: 29930717
[TBL] [Abstract][Full Text] [Related]
39. OCT4 expression in human uterine myometrial stem/progenitor cells.
Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
[TBL] [Abstract][Full Text] [Related]
40. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer.
Gazouli M; Roubelakis MG; Theodoropoulos GE; Papailiou J; Vaiopoulou A; Pappa KI; Nikiteas N; Anagnou NP
Mol Carcinog; 2012 Feb; 51(2):165-73. PubMed ID: 21480394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
